Core Viewpoint - MariMed Inc. has decided to exit the Missouri cannabis market to focus on higher return opportunities in its core markets, which is expected to enhance overall financial performance, particularly gross margin and adjusted EBITDA [3][4]. Group 1: Business Operations - Since 2024, MariMed managed Missouri operations under a Managed Services and Licensing Agreement but will cease management and not pursue license transfer [2]. - The company continues to operate in six states, with 13 dispensaries and six cultivation and processing facilities in Delaware, Illinois, Maryland, Massachusetts, Ohio, and Pennsylvania [3]. Group 2: Strategic Focus - The decision to exit Missouri is based on the conclusion that achieving scale in that market would require significant resources better allocated to core markets where MariMed has established strong positions [4]. - MariMed will consider future licensing opportunities in Missouri with a vertical operator if it aligns with financial goals and supports its ambition to become a cannabis consumer packaged goods powerhouse [4]. Group 3: Company Overview - MariMed is recognized as a leading multi-state cannabis operator, known for its award-winning portfolio of brands, including Betty's Eddies™, Bubby's Baked™, Vibations™, InHouse™, and Nature's Heritage™ [5]. - The company is committed to excellence and aims to drive growth while setting new standards in the cannabis industry [5].

NORWOOD, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced a licensing agreement with Farm 2 Hand, LLC (“Farm 2 Hand”), a New York State cannabis license holder, that will introduce the Company’s top-selling portfolio of products throughout New York State. Terms of the agreement were not disclosed. Farm 2 Hand intends to manufacture and distribute a variety of MariMed’s ...

Core Viewpoint - MariMed Inc. (MRMD) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook based on an upward trend in earnings estimates, which significantly influences stock prices [1][4]. Earnings Estimates and Revisions - The Zacks rating system focuses on changes in a company's earnings picture, with the Zacks Consensus Estimate tracking EPS estimates from sell-side analysts [2]. - MariMed Inc. is projected to earn -$0.02 per share for the fiscal year ending December 2025, showing no year-over-year change, but the Zacks Consensus Estimate has increased by 42.9% over the past three months [9]. Impact of Institutional Investors - Changes in earnings estimates are strongly correlated with stock price movements, as institutional investors use these estimates to determine the fair value of shares, leading to significant buying or selling activity [5]. Business Improvement Indicators - Rising earnings estimates and the Zacks rating upgrade suggest an improvement in MariMed Inc.'s underlying business, which could lead to higher stock prices as investors respond positively to this trend [6]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [8]. - MariMed Inc.'s upgrade to Zacks Rank 1 places it in the top 5% of Zacks-covered stocks, indicating strong potential for market-beating returns in the near term [11].

Core Points - InHouse™ has launched its second annual Help on the Homefront campaign to support veterans with housing costs and home improvements [1][4] - The campaign runs from October 1 to November 30, 2025, offering qualifying veterans a chance to win $5,000 to alleviate housing financial burdens [2] - One winner will be selected from each of four MariMed retail markets: Maryland, Massachusetts, Delaware, and Illinois [2] Company Overview - InHouse is a value-priced cannabis brand under MariMed Inc., offering a variety of high-quality products including flower, vapes, and gummies [5] - MariMed Inc. is recognized as a leading multi-state cannabis operator, known for its innovative cultivation, production, and retail facilities [6] - The company has a portfolio of award-winning cannabis brands, including InHouse, and is committed to excellence and growth in the cannabis industry [6]

Core Points - InHouse™ has launched its second annual Help on the Homefront campaign to support veterans with housing costs and home improvements, running from October 1 to November 30, 2025 [1][2] - The campaign aims to raise awareness about veteran housing challenges and homelessness, with one veteran from each of four states (Maryland, Massachusetts, Delaware, and Illinois) eligible to win $5,000 [1][2] - Veterans aged 21 and over can enter the contest either in-store at MariMed's Thrive dispensaries or online, with no purchase necessary [3] Company Overview - InHouse is a cannabis brand under MariMed Inc., offering a range of high-quality cannabis products including flower, vapes, and gummies [5] - MariMed Inc. is recognized as a leading multi-state cannabis operator, known for its innovative cultivation, production, and retail facilities, and has a portfolio of award-winning cannabis brands [6]

Core Viewpoint - MariMed Inc. is set to report its third quarter 2025 financial results on November 5, 2025, with a conference call scheduled for November 6, 2025, to discuss these results [1][2]. Company Overview - MariMed Inc. is a prominent multi-state cannabis operator, recognized for its advanced cultivation, production, and retail facilities [3]. - The company boasts an award-winning portfolio of cannabis brands, including Betty's Eddies™, Bubby's Baked™, InHouse™, Nature's Heritage™, and Vibations™, which are well-regarded by consumers nationwide [3]. - MariMed is committed to excellence and aims to drive growth while setting new standards in the cannabis industry [3].

Core Insights - Betty's Eddies™ has launched its third annual collaboration with the Keep A Breast Foundation to promote breast cancer awareness and education [1] - The campaign features a limited-time pink packaging for Ache Away Eddies fruit chews, which are infused with CBD, CBC, and THC, aimed at easing inflammation and aiding recovery [2] - The brand will donate $5 from each t-shirt sale to the Keep A Breast Foundation, further supporting its mission [3] Company and Industry Overview - MariMed Inc. is a leading multi-state cannabis operator known for its innovative cannabis brands, including Betty's Eddies™, and is committed to quality and excellence in the cannabis industry [6] - The partnership with the Keep A Breast Foundation has successfully reached thousands with education on early detection and screening for breast cancer [4] - Betty's Eddies aims to educate the community on health prioritization while highlighting the benefits of cannabis in providing relief from treatment-related ailments [5]

Core Insights - Betty's Eddies™ is collaborating with the Keep A Breast Foundation for the third consecutive year to promote breast cancer awareness and education on early screening [1][4] - The campaign features a limited-time pink packaging for Ache Away Eddies fruit chews, which are infused with CBD, CBC, THC, turmeric, piperine, and vitamin E, aimed at easing inflammation and aiding recovery [2][5] - The brand will donate $5 from each t-shirt sale to the Keep A Breast Foundation, further supporting its mission [3] Company Overview - Betty's Eddies is produced and distributed by MariMed Inc., a leading multi-state cannabis operator known for its innovative cannabis brands [1][6] - MariMed focuses on developing and managing advanced cultivation, production, and retail facilities, setting industry standards [6] Community Engagement - Betty's Eddies will participate in Susan G. Komen More Than Pink Walks in October 2025 to raise awareness and connect with local communities [4] - The partnership with the Keep A Breast Foundation has successfully reached thousands with education on early detection and screening [4]

Core Viewpoint - Momentum investing focuses on "buying high and selling higher" rather than the traditional "buying low and selling high" approach, aiming for quicker profits [1] Group 1: Momentum Investing Characteristics - Fast-moving trending stocks can be difficult to enter at the right time, as they may lose momentum if future growth does not justify high valuations [2] - A safer strategy involves investing in bargain stocks that exhibit recent price momentum, utilizing tools like the Zacks Momentum Style Score to identify such opportunities [3] Group 2: MariMed Inc. (MRMD) Analysis - MariMed Inc. (MRMD) has shown a significant price increase of 37.3% over the past four weeks, indicating growing investor interest [4] - The stock has gained 100% over the past 12 weeks, demonstrating its ability to deliver positive returns over a longer timeframe, with a beta of 3.01 indicating high volatility [5] - MRMD has a Momentum Score of B, suggesting it is an opportune time to invest in the stock to capitalize on its momentum [6] Group 3: Earnings Estimates and Valuation - An upward trend in earnings estimate revisions has contributed to MRMD earning a Zacks Rank 2 (Buy), as analysts raising estimates typically attract more investor interest [7] - MRMD is trading at a Price-to-Sales ratio of 0.35, indicating it is undervalued, as investors pay only 35 cents for each dollar of sales [7] Group 4: Additional Investment Opportunities - Besides MRMD, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, suggesting further investment opportunities [8] - The Zacks Premium Screens offer over 45 different strategies to help identify potential winning stocks based on various investing styles [9]

Core Insights - Momentum investors focus on "buying high and selling higher" rather than traditional strategies of buying low and waiting for recovery [1] - Identifying the right entry point for fast-moving stocks can be challenging, as they may lose momentum if future growth does not justify their high valuations [2] Group 1: Investment Strategy - A safer investment approach involves targeting bargain stocks that exhibit recent price momentum [3] - The Zacks Momentum Style Score aids in identifying strong momentum stocks by analyzing price and earnings trends [3] Group 2: MariMed Inc. (MRMD) Analysis - MariMed Inc. (MRMD) has shown significant price momentum, with a four-week price change of 58% and a 12-week gain of 114.2% [4][5] - MRMD has a high beta of 3, indicating it moves 200% more than the market in either direction, suggesting strong volatility [5] - The stock has a Momentum Score of B, indicating a favorable time to invest [6] Group 3: Earnings and Valuation - MRMD has received a Zacks Rank 2 (Buy) due to upward revisions in earnings estimates, which attract more investor interest [7] - The stock is currently trading at a Price-to-Sales ratio of 0.38, indicating it is undervalued at 38 cents for each dollar of sales [7] Group 4: Additional Opportunities - Besides MRMD, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, suggesting further investment opportunities [8] - Zacks offers over 45 Premium Screens tailored to different investing styles, which can help identify potential winning stocks [9]